As a confirmation of this hypothesis, Seipel et al. [37] have recently shown that restoring the TP53 function after treatment with cytotoxic chemotherapy compounds and TP53 restoring non-genotoxic agents induced CEBPA gene expression, myeloid differentiation, and cell-cycle arrest in AML cells. Here, TP53 is linked to acute myeloid leukemia.